Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 554-560

  Jiang, De Jian ^a   Cao, Yu ^a   Xin, Hong Ya ^b   Li, Xiao Hui ^a   Luo, Zi Qiang ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute coronary syndromes; Asymmetric dimethylarginine; Monocytes; Nuclear factor kappa B; Tissue factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N(G),N(G) DIMETHYLARGININE; THROMBOPLASTIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; TRANSCRIPTION REGULATION; UNSTABLE ANGINA PECTORIS; UPREGULATION;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; ARGININE; BLOOD COAGULATION; CASE-CONTROL STUDIES; COAGULANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; NITRIC OXIDE SYNTHASE; THROMBOPLASTIN;

EID: 67650915289     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.024     Document Type: Article

References (27)

1. Napoli C., and Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 5 (2001) 88-97
2. Böger R.H. Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med 41 (2003) 1467-1472
3. Takiuchi S., Fujii H., Kamide K., et al. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am J Hypertens 17 (2004) 802-808
4. Usui M., Matsuoka H., Miyazaki H., et al. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62 (1998) 2425-2430
5. Lu T.M., Ding Y.A., Charng M.J., and Lin S.J. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease. Clin Cardiol. 26 (2003) 458-464
6. Bae S.W., Stuhlinger M.C., Yoo H.S., et al. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 95 (2005) 729-733
7. Krempl T.K., Maas R., Sydow K., et al. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. Eur Heart J 26 (2005) 1846-1851
8. Lu T.M., Ding Y.A., Lin S.J., Lee W.S., and Tai H.C. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J. 24 (2003) 1912-1919
9. Schnabel R., Blankenberg S., Lubos E., et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97 (2005) e53-e59
10. Valkonen V.P., Paiva H., Salonen J.T., et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 358 (2001) 2127-2128
11. Moons A.H., Levi M., and Peters R.J. Tissue factor and coronary artery disease. Cardiovasc Res 53 (2002) 313-325
12. Moreno P.R., Bernardi V.H., Lopez-Cuellar J., et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 4 (1996) 3090-3097
13. Jude B., Agraou B., McFadden E.P., et al. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 90 (1994) 1662-1668
14. Mallat Z., Benamer H., Hugel B., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101 (2000) 841-843
15. Herbert J.M., Savi P., Laplace M.C., and Lale A. IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 310 (1992) 31-33
16. Cadroy Y., Dupouy D., Boneu B., and Plaisancie H. Polymorphonuclear leukocytes modulate tissue factor production by mononuclear cells: role of reactive oxygen species. J Immunol 164 (2000) 3822-3828
17. Böger R.H., Bode-Böger S.M., Tsao P.S., et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 36 (2000) 2287-2295
18. Jiang D.J., Jiang J.L., Tan G.S., et al. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine. Naunyn Schmiedebergs Arch Pharmacol 367 (2003) 600-606
19. Simeonidis S., Castagliuolo I., Pan A., et al. Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter. Proc Natl Acad Sci USA 100 (2003) 2957-2962
20. Oeth P.A., Parry G.C., Kunsch C., et al. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol 14 (1994) 3772-3781
21. Jiang D.J., Jia S.J., Dai Z., and Li Y.J. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells. J Mol Cell Cardiol 40 (2006) 529-539
22. Smirnova I.V., Kajstura M., Sawamura T., and Goligorsky M.S. Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation. Am J Physiol Heart Circ Physiol. 287 (2004) H782-H790
23. Thum T., Tsikas D., Stein S., et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46 (2005) 1693-1701
24. Cermak J., Key N.S., Bach R.R., et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82 (1993) 513-520
25. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 78 (1997) 747-754
26. Zhang W.Z., Venardos K., Chin-Dusting J., and Kaye D.M. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension 48 (2006) 278-285
27. Lin K.Y., Ito A., Asagami T., et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106 (2002) 987-992